Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab-Reference-Cited by-同舟云学术

Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab

Published:2013-06-28 Issue:2 Volume:72 Page:453-461
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Hellmann Matthew D.,Chaft Jamie E.,Rusch Valerie,Ginsberg Michelle S.,Finley David J.,Kris Mark G.,Price Katharine A. R.,Azzoli Christopher. G.,Fury Matthew G.,Riely Gregory J.,Krug Lee M.,Downey Robert J.,Bains Manjit S.,Sima Camelia S.,Rizk Nabil,Travis William D.,Rizvi Naiyer A.,Paik Paul K.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-013-2219-5.pdf

Reference33 articles.

1. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186

2. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

3. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7:1194–1201

4. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676

5. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3:401–410

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Volatile organic compounds in exhaled breath: a promising approach for accurate differentiation of lung adenocarcinoma and squamous cell carcinoma;Journal of Breath Research;2024-08-05

2. V6 vein-preserving superior segmentectomy: A potentially preferable option;Heliyon;2024-05

3. IRF7 and IFIT2 in mediating different hemorrhage outcomes for non-small cell lung cancer after bevacizumab treatment;Journal of Thoracic Disease;2023-04

4. Angiogenesis as a hallmark of solid tumors - clinical perspectives;Cellular Oncology;2021-04-09

5. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma;Journal of Computational Biology;2020-07-01